VIP BRAZIL- RESOURCE USE AND ASSOCIATED COSTS OF THROMBOTIC EVENTS AFTER TOTAL KNEE REPLACEMENT (TKR) SURGERY IN BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
Author(s)
Nita ME1, Comparini LB1, Mainine S2, Santinho CS1, Fujii RK3, Mussolino F4, Rached R1, Rahal E11Bristol-Myers Squibb S/A, São Paulo, SP, Brazil, 2Hospital Estadual Mario Covas, Santo Andre, Sao Paulo, Brazil, 3Pfizer, Inc., São Paulo, São Paulo, Brazil, 4NEW BD - Business Developers, São Paulo, SP, Brazil
OBJECTIVES: Patients undergoing total knee or hip replacement are at high risk of experiencing venous thromboembolism (VTE) - deep vein thrombosis (DVT) and pulmonary embolism (PE), therefore, the aim of this study was to estimate resource utilization and associated costs of VTE following TKR under SUS perspective. METHODS: Data analysis was conducted through a review of a government administrative claims database (DATASUS). A cohort of patients who underwent TKR surgery in the public healthcare system was defined (1/2010 - 9/2010) and followed for 6 months after surgery. Data regarding total hospitalization costs were compared for patients who didn’t present complications with patients who presented VTE events. RESULTS: A total of 4736 patients were identified between January 2010 to September 2010 with average age of 65,6 years (SD 10,3), being 72.1% female. Mean hospitalization costs per patient were $BRL4,036 (SD 2,063) for the population analyzed. VTE episodes were experienced by 42 patients (0,89%, 32 cases of DVT and 10 of PE) and were associated with higher hospitalizations costs than patients without any complication: $BRL3,919 (SD 1,811), $BRL4,581 (SD 2,362) and $BRL7,715 (SD 6,777) for patients without complication, DVT and PE respectively. CONCLUSIONS: Patients experiencing VTE following TKR surgery represents a significant economic burden for the Brazilian public health care system. Our study suggests that a patient who presents PE following TKR surgery can cost twice more than a patient without complications.
Conference/Value in Health Info
2012-06, ISPOR 2012, Washington, D.C., USA
Value in Health, Vol. 15, No. 4 (June 2012)
Code
PCV103
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Cardiovascular Disorders